SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-161541
Filing Date
2018-05-14
Accepted
2018-05-14 07:01:51
Documents
66
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d577633d10q.htm 10-Q 745029
2 EX-31.1 d577633dex311.htm EX-31.1 7037
3 EX-31.2 d577633dex312.htm EX-31.2 6506
4 EX-32.1 d577633dex321.htm EX-32.1 3474
5 EX-32.2 d577633dex322.htm EX-32.2 3506
  Complete submission text file 0001193125-18-161541.txt   3746680

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT umrx-20180331.xml EX-101.INS 615100
7 XBRL TAXONOMY EXTENSION SCHEMA umrx-20180331.xsd EX-101.SCH 41421
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE umrx-20180331_cal.xml EX-101.CAL 57200
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE umrx-20180331_def.xml EX-101.DEF 146588
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE umrx-20180331_lab.xml EX-101.LAB 340647
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE umrx-20180331_pre.xml EX-101.PRE 252516
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 18828644
SIC: 2834 Pharmaceutical Preparations